News from stryker A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 26, 2018, 07:32 ET Resultados do estudo clínico DAWN da Stryker contribuem para atualizar as diretrizes da Associação Americana de Cardiologia e da Associação Americana de Acidente Vascular Cerebral para o acidente vascular cerebral isquêmico agudo

A Associação Americana de Cardiologia e a Associação Americana de Acidente Vascular Cerebral atualizaram ontem as diretrizes para o acidente vascular ...


Jan 25, 2018, 02:44 ET Stryker's DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association

Yesterday the American Heart Association and American Stroke Association updated the ischemic stroke guidelines. The new recommendation expanded the...


Nov 15, 2017, 01:00 ET Communiqué de Stryker France MM Holdings SAS de mise à disposition de la note d'information et du document "autres informations" relatif aux caractéristiques, notamment juridiques, financières et comptables de Stryker France MM Holdings SAS

PRIX DE L'OFFRE : 20,00 euros par action Vexim 3,91 euros par BSAAR Vexim DUREE DE L'OFFRE : 15 jours de négociation Le présent communiqué est établi ...


Nov 14, 2017, 07:22 ET Stryker annonce la publication des résultats de l'étude DAWN™ dans le New England Journal of Medicine

Le New England Journal of Medicine a publié les résultats de l'étude DAWN, la première étude à fournir des preuves convaincantes concernant le...


Nov 14, 2017, 06:56 ET Stryker anuncia la publicación de los resultados del ensayo DAWN™ en The New England Journal of Medicine

The New England Journal of Medicine ha publicado los resultados del ensayo DAWN, el primero que ofrece pruebas rotundas sobre el tratamiento mediante ...


Nov 14, 2017, 06:53 ET Stryker gibt Veröffentlichung der Ergebnisse der DAWN™-Studie im New England Journal of Medicine bekannt

Das New England Journal of Medicine hat die Ergebnisse der DAWN-Studie veröffentlicht, die als erste Studie überzeugende Beweise für eine Behandlung...


Nov 13, 2017, 18:48 ET Stryker anuncia a publicação dos resultados do teste DAWN™ no New England Journal of Medicine

O New England Journal of Medicine publicou os resultados do teste DAWN, o primeiro a fornecer evidências contundentes sobre o tratamento de pacientes ...


Nov 13, 2017, 13:38 ET Stryker anuncia la publicación de los resultados de los ensayos DAWN™ en la New England Journal of Medicine

La New England Journal of Medicine publicó los resultados del ensayo DAWN, el primero en ofrecer prueba convincente en el tratamiento de pacientes...


Nov 13, 2017, 07:21 ET Stryker announces publication of the DAWN™ Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and...


Nov 09, 2017, 07:30 ET Stryker receives US FDA HDE approval for the Neuroform Atlas™ Stent System to treat wide neck aneurysms

Stryker Corporation announced today that the U.S. Food and Drug Administration has approved the Neuroform Atlas™ Stent System for marketing under a...


Oct 30, 2017, 09:00 ET Stryker's Performance Solutions Launches Practice Excellence™ Program to Help Physician Practices Drive Profitability, Efficiency & Quality Outcomes

Performance Solutions, Stryker's healthcare transformation business, today announced the launch of its Practice Excellence™ Program, a new...


Oct 26, 2017, 11:00 ET Stryker destaca a importância de reconhecer os sinais do derrame no Dia Mundial do AVC

Em homenagem ao Dia Mundial do AVC, a Stryker lembra as pessoas sobre a importância de reconhecer os sinais do derrame. Durante um derrame, 1,9...


Oct 26, 2017, 10:57 ET Stryker destaca la importancia de reconocer los signos del ictus en el Día Mundial del Ictus

En honor del Día Mundial del Ictus, Stryker recuerda a la sociedad la importancia de poder reconocer a tiempo los signos del ictus. Durante un ictus, ...


Oct 26, 2017, 10:22 ET Welt-Schlaganfall-Tag: Stryker erinnert daran, wie wichtig es ist, die Anzeichen eines Schlaganfalls zu erkennen

Zum Welt-Schlaganfall-Tag möchte Stryker daran erinnern, wie wichtig es ist, die Anzeichen eines Schlaganfalls zu erkennen. Bei einem Schlaganfall...


Oct 26, 2017, 10:19 ET Per la Giornata mondiale dell'ictus, Stryker sottolinea l'importanza di riconoscere i segni dell'ictus

In onore della Giornata mondiale dell'ictus, Stryker ricorda alle persone l'importanza di riconoscere i segni dell'ictus. Durante un ictus si perdono ...


Oct 26, 2017, 10:18 ET Stryker destaca la importancia de reconocer los signos del ictus en el Día Mundial del Ictus

En honor del Día Mundial del Ictus, Stryker recuerda a la sociedad la importancia de poder reconocer a tiempo los signos del ictus. Durante un ictus, ...


Oct 26, 2017, 10:16 ET Stryker souligne l'importance de reconnaître les signes d'un AVC pour la journée mondiale de l'accident vasculaire cérébral

À l'occasion de la journée mondiale de l'accident vasculaire cérébral, Stryker rappelle à la population l'importance de reconnaître les signes d'un...


Oct 26, 2017, 09:54 ET Stryker Highlights Importance of Recognizing Stroke Signs for World Stroke Day

In honor of World Stroke Day, Stryker reminds the public about the importance of recognizing the signs of a stroke. During a stroke, 1.9 million...


Oct 25, 2017, 15:01 ET Communiqué de Stryker relatif au dépôt d'un projet d'offre publique d'achat simplifiée visant les actions et bons de souscription et/ou d'acquisition d'actions remboursables de la société Vexim

PRIX DE L'OFFRE : 20,00 euros par action Vexim 3,91 euros par BSAAR Vexim DUREE DE L'OFFRE : 15 jours de négociation Le présent communiqué relatif au ...


Oct 24, 2017, 16:00 ET Stryker annonce l'acquisition de VEXIM

Stryker Corporation (NYSE: SYK) annonce avoir acquis le contrôle de VEXIM, une société française de dispositifs médicaux cotée sur le marché Euronext ...


Oct 16, 2017, 09:00 ET Stryker Receives FDA Clearance for Cementless Mako Total Knee with Triathlon® Tritanium®

Stryker's Joint Replacement division today announced that its cementless Mako Total Knee with Triathlon Tritanium has received 510(k) market...


Sep 19, 2017, 09:00 ET The Mobility Zone Closes Out 2017 Season With Return to TOUR Championship

This week, Stryker Orthopaedics will round out its fourth year as the Official Joint Replacement Products of the PGA TOUR® and PGA TOUR Champions at...


Jul 11, 2017, 09:00 ET Stryker's MultiGen® 2 Radiofrequency Generator Receives FDA 510(k) Clearance

Stryker announced today that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. This product provides physicians with the...


Jun 07, 2017, 09:00 ET Stryker Heads To The Midwest For First PGA TOUR Champions Stop Of The Year

Stryker Orthopaedics will make its first PGA TOUR Champions appearance of 2017 at The Principal Charity Classic in Des Moines, Iowa. During the...


May 24, 2017, 09:00 ET Stryker Returns To DEAN & DELUCA Invitational For Second Consecutive Year With Plans To Honor Military Veteran With Service Canine

Stryker Orthopaedics announced today plans to activate in Fort Worth, TX for the DEAN & DELUCA Invitational. For the second consecutive year...